Join the Irritable Bowel Syndrome group to help and get support from people like you.
Irritable Bowel Syndrome News
Related terms: IBS, Spastic colon
Dietary Changes May Beat Meds in Treating IBS
FRIDAY, April 19, 2024 – The right diet may be the best medicine for easing the painful symptoms of irritable bowel syndrome (IBS), new research shows. In the study, two different eating plans beat...
Healthy Living Can Prevent Irritable Bowel Syndrome
WEDNESDAY, Feb. 21, 2024 – Folks who follow a healthy lifestyle are less likely to wind up with a case of irritable bowel syndrome (IBS), a new study claims. The more healthy behaviors in which a...
Healthy Lifestyle Cuts Risk for Irritable Bowel Syndrome
WEDNESDAY, Feb. 21, 2024 – Adhering to a higher number of healthy lifestyle behaviors is significantly associated with a lower incidence of irritable bowel syndrome (IBS), according to a study...
American College of Gastroenterology, Oct. 20-25
The annual meeting of the American College of Gastroenterology was held from Oct. 20 to 25 in Vancouver, British Columbia, Canada, and attracted participants from around the world, including...
ACG: Combined Oral Contraceptives Increase Risk for Irritable Bowel Syndrome
TUESDAY, Oct. 24, 2023 – Combined oral contraceptives (COCs) are associated with higher risks for developing irritable bowel syndrome (IBS) and its subtypes, according to a study presented at the...
Commonly Used Drug Amitriptyline Might Be New Treatment Option for IBS
WEDNESDAY, Oct. 18, 2023 – An inexpensive medication long used for depression and migraines now has a clinical trial to back up its off-label use for another condition that lowers quality of life:...
Specific GI Syndromes Linked to Parkinson Disease
FRIDAY, Aug. 25, 2023 – Specific gastrointestinal (GI) syndromes including dysphagia, gastroparesis, constipation, and irritable bowel syndrome (IBS) without diarrhea are associated with Parkinson...
What Is Irritable Bowel Syndrome?
WEDNESDAY, June 7, 2023 – People who suffer from irritable bowel syndrome (IBS) know it is a highly unpleasant chronic condition that can trigger abdominal pain, diarrhea and constipation. Here,...
FDA Approves Ibsrela (tenapanor) for the Treatment of Irritable Bowel Syndrome with Constipation
FREMONT, Calif., Sept. 12, 2019 /PRNewswire/ – Ardelyx, Inc. today announced that the U.S. Food and Drug Administration has approved Ibsrela (tenapanor), a 50 mg, twice daily oral pill for the...
FDA Approves the Reintroduction of Zelnorm (tegaserod) for Irritable Bowel Syndrome with Constipation (IBS-C) in Women Under 65
LOUISVILLE, Ken., April 1, 2019 /PRNewswire/ – US WorldMeds has announced that Sloan Pharma, S.a.r.l., a subsidiary of US WorldMeds Holdings, LLC, has received approval from the U.S. Food and Drug...
Synergy Pharmaceuticals Announces FDA Approval of Trulance (plecanatide) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults
NEW YORK--(BUSINESS WIRE) January 25, 2018 – Synergy Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Trulance (plecanatide) 3 mg tablet for the...
FDA Medwatch Alert: Viberzi (eluxadoline): Drug Safety Communication - Increased Risk of Serious Pancreatitis In Patients Without A Gallbladder
ISSUE: FDA is warning that Viberzi (eluxadoline), a medicine used to treat irritable bowel syndrome with diarrhea (IBS-D), should not be used in patients who do not have a gallbladder. An FDA review...
FDA Medwatch Alert: Hyoscyamine sulfate 0.125mg by Virtus Pharmaceuticals: Recall - Superpotent and Subpotent Test Results
ISSUE: Virtus Pharmaceuticals Opco II, LLC (Virtus) is voluntarily recalling seven batches of Hyoscyamine sulfate (0.125mg) to the consumer level which include the tablet, sublingual, and orally...
FDA Approves Xifaxan (rifaximin) for the Treatment of IBS-D (Irritable Bowel Syndrome with Diarrhea)
LAVAL, Quebec, May 27, 2015 /PRNewswire/ – Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that its wholly owned subsidiary, Salix Pharmaceuticals, Inc., has received...
FDA Approves Viberzi (eluxadoline) for Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults
DUBLIN, May 27, 2015 /PRNewswire/ – Actavis plc (NYSE: ACT) announced today that Viberzi (eluxadoline) was approved by the Food and Drug Administration (FDA) as a twice-daily, oral treatment for...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Related drug support groups
escitalopram, amitriptyline, venlafaxine, MiraLax, Linzess, nortriptyline, dicyclomine, Bentyl, Metamucil, view more... clomipramine, Imodium, doxepin, cholestyramine, Amitiza, Xifaxan